Istvan Redei

647 total citations
17 papers, 483 citations indexed

About

Istvan Redei is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Istvan Redei has authored 17 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Istvan Redei's work include Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (5 papers) and Polyomavirus and related diseases (4 papers). Istvan Redei is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), T-cell and B-cell Immunology (5 papers) and Polyomavirus and related diseases (4 papers). Istvan Redei collaborates with scholars based in United States. Istvan Redei's co-authors include Edmund K. Waller, Sagar Lonial, Amelia Langston, Hilary Rosenthal, Jyoti Somani, Andrew J. Allen, Michael W. Boyer, Jennifer L. Peel, Ingrid Jurickova and Angela M. Caliendo and has published in prestigious journals such as Blood, Cancer and Bone Marrow Transplantation.

In The Last Decade

Istvan Redei

17 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Istvan Redei United States 11 277 237 140 87 75 17 483
L Barnett United States 10 424 1.5× 337 1.4× 121 0.9× 46 0.5× 52 0.7× 16 578
MJ van Tol Netherlands 9 289 1.0× 258 1.1× 74 0.5× 64 0.7× 53 0.7× 12 450
F. Falkenburg Netherlands 4 417 1.5× 406 1.7× 156 1.1× 53 0.6× 52 0.7× 5 639
Anandharaman Veerapathran United States 11 217 0.8× 340 1.4× 132 0.9× 92 1.1× 97 1.3× 15 569
Yasemin Kilical United States 5 240 0.9× 302 1.3× 191 1.4× 41 0.5× 81 1.1× 9 476
Renee J. Robb Australia 11 310 1.1× 513 2.2× 123 0.9× 42 0.5× 121 1.6× 12 686
James Morton Australia 12 329 1.2× 136 0.6× 134 1.0× 96 1.1× 64 0.9× 22 464
A Beauplet France 6 196 0.7× 203 0.9× 54 0.4× 38 0.4× 57 0.8× 12 482
Mateja Kralj Juric Austria 6 249 0.9× 207 0.9× 96 0.7× 85 1.0× 102 1.4× 7 454
Hironari Niiya Japan 13 169 0.6× 155 0.7× 144 1.0× 145 1.7× 77 1.0× 18 430

Countries citing papers authored by Istvan Redei

Since Specialization
Citations

This map shows the geographic impact of Istvan Redei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Istvan Redei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Istvan Redei more than expected).

Fields of papers citing papers by Istvan Redei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Istvan Redei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Istvan Redei. The network helps show where Istvan Redei may publish in the future.

Co-authorship network of co-authors of Istvan Redei

This figure shows the co-authorship network connecting the top 25 collaborators of Istvan Redei. A scholar is included among the top collaborators of Istvan Redei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Istvan Redei. Istvan Redei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brinker, Brett T., Edmund K. Waller, Traci Leong, et al.. (2006). Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma. Cancer. 106(10). 2171–2180. 36 indexed citations
2.
Waller, Edmund K., Cynthia R. Giver, Hilary Rosenthal, et al.. (2004). Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood Cells Molecules and Diseases. 33(3). 233–237. 19 indexed citations
3.
4.
Langston, Amelia, Sagar Lonial, Kenneth J. Smith, et al.. (2004). A Phase I Trial of Ara-C, Topotecan, and Gemtuzumab Ozogamicin (Mylotarg®) for Advanced MDS and Secondary or Relapsed AML.. Blood. 104(11). 1814–1814. 1 indexed citations
5.
Castellano‐Sanchez, Amilcar A., et al.. (2003). Acanthamoeba castellani encephalitis following partially mismatched related donor peripheral stem cell transplantation. Transplant Infectious Disease. 5(4). 191–194. 25 indexed citations
6.
Waller, Edmund K., Amelia Langston, Sagar Lonial, et al.. (2003). Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biology of Blood and Marrow Transplantation. 9(7). 460–471. 101 indexed citations
7.
8.
Langston, Amelia, Istvan Redei, Angela M. Caliendo, et al.. (2002). Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood. 99(3). 1085–1088. 62 indexed citations
9.
Waller, Edmund K., Hilary Rosenthal, Jennifer L. Peel, et al.. (2001). Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood. 97(10). 2948–2956. 113 indexed citations
10.
Waller, Edmund K., Istvan Redei, William H. Fleming, et al.. (1998). Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation. 5(4). 221–228. 4 indexed citations
11.
Redei, Istvan, et al.. (1997). Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions. Bone Marrow Transplantation. 19(2). 175–177. 12 indexed citations
12.
13.
14.
Goldberg, Steven L., et al.. (1996). Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.. PubMed. 18(3). 633–6. 12 indexed citations
15.
Scher, Richard M., et al.. (1995). Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas. Investigational New Drugs. 13(4). 347–354. 29 indexed citations
16.
Redei, Istvan & Ronald N. Rubin. (1995). Techniques for evaluating the cause of bleeding in the ICU. Diagnostic clues and keys to interpreting hemostatic tests.. PubMed. 10(2). 133–7. 2 indexed citations
17.
Redei, Istvan, et al.. (1994). Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer. Investigational New Drugs. 12(4). 319–321. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Barnett Breakdown of academic impact, for papers by MJ van Tol Breakdown of academic impact, for papers by F. Falkenburg Breakdown of academic impact, for papers by Anandharaman Veerapathran Breakdown of academic impact, for papers by Yasemin Kilical Breakdown of academic impact, for papers by Renee J. Robb Breakdown of academic impact, for papers by James Morton Breakdown of academic impact, for papers by A Beauplet Breakdown of academic impact, for papers by Mateja Kralj Juric Breakdown of academic impact, for papers by Hironari Niiya
Rankless by CCL
2026